Insider Trading March 19, 2026

Fairholme Funds Disposes $1.52M in St. Joe Shares; Stake Remains Substantial

21,100 shares sold near 52-week high as firm and controlling investor maintain significant holdings

By Leila Farooq JOE
Fairholme Funds Disposes $1.52M in St. Joe Shares; Stake Remains Substantial
JOE

Fairholme Funds Inc., a roughly 10% holder of The St. Joe Company (NYSE: JOE), executed a sale of 21,100 shares on March 17, 2026, for $72.22 per share, totaling $1.52 million. The transaction occurred close to JOE's 52-week peak and follows a year of notable stock appreciation. Following the sale, Fairholme continues to directly hold more than 16 million shares. Recent company results for Q4 2025 showed revenue growth and solid earnings, while some analysts have raised outlooks.

Key Points

  • Fairholme Funds Inc., a roughly 10% owner of The St. Joe Company, sold 21,100 shares on March 17, 2026, at $72.22 per share for a total of $1.52 million.
  • After the sale Fairholme directly holds 16,073,624 shares; Bruce R. Berkowitz may be deemed to have beneficial ownership through control of the fund manager and also directly owns 606,866 shares.
  • St. Joe reported Q4 2025 revenue of $128.9 million, up 24% year over year, and EPS of $0.52; InvestingPro analysis indicates JOE appears overvalued relative to its Fair Value.

Fairholme Funds Inc., identified as a 10 percent owner of The St. Joe Company (NYSE: JOE), reported a sale of 21,100 common shares on March 17, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were disposed of at $72.22 each, yielding a transaction value of approximately $1.52 million.

The sale price landed close to JOE's 52-week high of $73.54 and comes after the stock recorded a 48% gain over the prior 12 months. Despite the disposition, Fairholme retains a substantial direct position in the company, holding 16,073,624 shares after the March 17 trade.

The filing also notes that Bruce R. Berkowitz may be viewed as having beneficial ownership of the securities. That determination stems from his control of the sole member of Fairholme Capital Management, LLC, which serves as the investment manager to the Fairholme Fund. In addition to potential indirect ownership through the fund, Berkowitz holds 606,866 shares in his own name.

Separately, analysis available through InvestingPro indicates that JOE currently appears overvalued relative to its Fair Value. The platform references a Pro Research Report covering the company, one of more than 1,400 reports on US equities, and highlights additional research tools and commentary accessible to subscribers.

Corporate results released for the fourth quarter of 2025 provide context for the stock's recent strength. The St. Joe Company reported revenue of $128.9 million for the period, an increase of 24% compared with the same quarter a year earlier. The company recorded earnings per share of $0.52 for Q4 2025. Those results exceeded many forecasts and have prompted some analysts to raise their outlooks for the stock.

Market participants and the financial community continue to monitor both insider activity and the company’s financial performance as indicators of sentiment and operational momentum. The March 17 sale reduced Fairholme's position by a small fraction while leaving its overall stake large by common shareholder standards.


Summary

Fairholme Funds sold 21,100 shares of St. Joe at $72.22 on March 17, 2026, totaling $1.52 million, and continues to hold 16,073,624 shares. Bruce R. Berkowitz may be deemed a beneficial owner and directly owns 606,866 shares. InvestingPro flags JOE as appearing overvalued versus Fair Value. The St. Joe Company posted Q4 2025 revenue of $128.9 million, up 24% year over year, with EPS of $0.52, prompting some analyst upgrades.

Risks

  • Insider sales, even relatively small ones, can be interpreted variably by market participants and may influence investor sentiment in the real estate and equity markets.
  • Valuation assessments that label JOE as overvalued relative to Fair Value introduce uncertainty for investors relying on price-to-fair-value comparisons when making allocation decisions.
  • Future stock performance could be affected if subsequent insider transactions or analyst revisions diverge from recent positive earnings results, impacting market perception in financial and real estate sectors.

More from Insider Trading

Tarsus Pharmaceuticals general counsel completes $850K in mandated stock sales Mar 19, 2026 Tarsus Pharmaceuticals CHRO Executes $839K in Share Sales to Cover RSU Taxes Mar 19, 2026 Tarsus Pharmaceuticals CCO Sells $892,528 in Share Transaction Over Three Days Mar 19, 2026 Tarsus Pharmaceuticals COO Disposes $772K of Stock to Cover RSU Taxes Mar 19, 2026 Travel & Leisure General Counsel Sells $2.2M in Stock as Sector Updates Surface Mar 19, 2026